Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$19.02 - $30.13 $184,494 - $292,261
9,700 Added 72.02%
23,169 $515,000
Q3 2023

Nov 14, 2023

BUY
$30.46 - $46.04 $410,265 - $620,112
13,469 New
13,469 $410,000
Q1 2023

May 09, 2023

SELL
$29.72 - $41.45 $140,516 - $195,975
-4,728 Reduced 24.92%
14,241 $455,000
Q4 2022

Feb 14, 2023

BUY
$30.23 - $38.71 $302,420 - $387,254
10,004 Added 111.59%
18,969 $677,000
Q3 2022

Feb 14, 2023

SELL
$22.51 - $38.27 $262,984 - $447,108
-11,683 Reduced 56.58%
8,965 $260,000
Q2 2022

Aug 08, 2022

BUY
$20.97 - $37.47 $125,065 - $223,471
5,964 Added 40.62%
20,648 $463,000
Q1 2022

May 16, 2022

BUY
$34.38 - $65.77 $284,803 - $544,838
8,284 Added 129.44%
14,684 $542,000
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $408,192 - $626,304
6,400 New
6,400 $452,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.